Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

ABN1650 Anti-Aβ-42 Antibody, oligomeric (VIA)

Anti-Aβ-42, oligomeric (VIA), Cat. No. ABN1650, is a highly specific rabbit polyclonal antibody that targets oligomeric amyloid beta 42 and has been tested in Dot Blot, Immunofluorescence, Immunohistochemistry, and Western Blotting.

Anti-Aβ-42 Antibody, oligomeric (VIA) MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Research Category: Neuroscience Gene Symbol: APP, A4, AD1 UniProt Number: P05067
View Products on Sigmaaldrich.com
ABN1650
100 µL  
Purchase on Sigma-Aldrich

Special Offers

Overview

Replacement Information

Special Offers

100% Performance Guaranteed

Key Spec Table

Species ReactivityKey ApplicationsHostFormatAntibody Type
HDB, IF, IHC, WBRbSerumPolyclonal Antibody
Description
Catalogue NumberABN1650
DescriptionAnti-Aβ-42 Antibody, oligomeric (VIA)
Alternate Names
  • Aβ-42 oligomer
  • Abeta-42 oligomer
  • Oligomeric Aβ-42
  • Oligomeric Abeta-42
Background InformationAmyloid beta A4 protein (UniProt P05067; also known as ABPP, Alzheimer disease amyloid protein, Amyloid precursor protein, APP, APPI, Cerebral vascular amyloid peptide, CVAP, PN-II, PreA4, Protease nexin-II) is encoded by the APP (also known as A4, AD1) gene (Gene ID 351) in human. Amyloid precursor protein (APP) is initially produced with a signal peptide sequence (a.a. 1-17), the removal of which yields the mature protein with a large extracellular portion (a.a. 18-699), followed by a transmembrane segment (a.a. 700-723) and a cytoplasmic (a.a. 724-770) tail. APP can be further processed by the α-, β-, and γ-secretases in two alternative processing pathways. In the non-amyloidogenic pathway, APP is first cleaved by the plasma membrane-localized α-secretase to generate an N-terminal extracellular sAPPα fragment (a.a. 18-687) and a membrane-bound C-terminal fragment C83 (CTFα), which can be further cleaved by γ-secretase to produce a non-toxic small peptide p3 and a cytoplasmic APP intracellular domain (AICD). In the amyloidogenic pathway, APP undergoes β-cleavage in BACE-1 (β-site APP-cleaving enzyme)-enriched endosomes to generate an N-terminal extracellular sAPPβ fragment (a.a. 18-671) and a membrane-bound C-terminal fragment C99 (CTFβ). Subsequent cleavage of C99 by γ-secretase releases the amyloid β peptides, Aβ1-42 (672-713) & Aβ1-40 (672-711), and AICD. Aβ accumulation in the cortical and hippocampal regions of the brain is a major pathological feature of Alzheimer's disease (AD). Growing evidences implicate soluble oligomers as the more toxic species and the extent of oligomer formation and assembly correlates better with disease progression and cognitive dysfunction. These Aβ oligomers are able to induce other aggregation-prone proteins, including α-synuclein (α-syn), prion protein (PrP), and TDP-43, to assume oligomeric conformations. These proteins can then seed tau aggregation, resulting in neurodegeneration.
References
Product Information
FormatSerum
PresentationRabbit polyclonal antibody serum with 0.05% sodium azide.
Quality LevelMQ100
Applications
ApplicationAnti-Aβ-42, oligomeric (VIA), Cat. No. ABN1650, is a highly specific rabbit polyclonal antibody that targets oligomeric amyloid beta 42 and has been tested in Dot Blot, Immunofluorescence, Immunohistochemistry, and Western Blotting.
Key Applications
  • Dot Blot
  • Immunofluorescence
  • Immunohistochemistry
  • Western Blotting
Application NotesImmunofluorescence Analysis: A 1:150 dilution from a representative lot detected oligomeric Aβ-42, but not oligomeric Tau or large amyloid plaques in Alzheimer's diseased (AD) human brain cryosections (Courtesy of Riddhi U Bodani, Kayed lab, Univ of Texas Medical Branch, Galveston, U.S.A.).

Immunohistochemistry Analysis: A 1:150 dilution from a representative lot detected oligomeric Aβ-42 immunoreactivity in Alzheimer's diseased (AD) human cortex cryosections (Courtesy of Riddhi U Bodani, Kayed lab, Univ of Texas Medical Branch, Galveston, U.S.A.).

Dot Blot Analysis: A representative lot detected recombinant Aβ-42, but not Aβ-40, oligomers (Bodani, R.U., et al. (2015). ACS Chem. Neurosci. 6(12):1981-1989).

Immunofluorescence Analysis: A representative lot immunostained both prefibrillar and fibrillar Aβ-42 oligomers in Alzheimer's diseased (AD) human brain (Bodani, R.U., et al. (2015). ACS Chem. Neurosci. 6(12):1981-1989).

Immunofluorescence Analysis: A representative lot detected oligomeric Aβ-42, but not amyloid plaques in coronal sections of Tg2576AD mice harboring human Swedish mutation APP (APPK670/671L) transgene (Bodani, R.U., et al. (2015). ACS Chem. Neurosci. 6(12):1981-1989).

Immunohistochemistry Analysis: A representative lot immunostained intracellular perinuclear Aβ-42 aggregates, but not amyloid plaques in Alzheimer's diseased (AD) human brain (Bodani, R.U., et al. (2015). ACS Chem. Neurosci. 6(12):1981-1989).

Immunohistochemistry Analysis: A representative lot detected oligomeric Aβ-42 immunoreactivity in the hippocampus CA1 region of Tg2576AD mice harboring human Swedish mutation APP (APPK670/671L) transgene (Bodani, R.U., et al. (2015). ACS Chem. Neurosci. 6(12):1981-1989).

Western Blotting Analysis: A representative lot detected oligomeric A -42, but not monomeric Aβ-42, monomeric or oligomeric Aβ-40 (Bodani, R.U., et al. (2015). ACS Chem. Neurosci. 6(12):1981-1989).

Note: Both purified antibody (Cat. No. ABN1665) and unpurified antiserum (Cat. No. ABN1650) are suitable for Dot blot, immunofluorescence, immunohistochemistry, and Western blotting applications. However, we recommend using only the purified antibody for neutralization studies.
Biological Information
ImmunogenAggregated synthetic hexapeptide VIAVIA composed of two copies of Aβ-42 C-terminal end 3-amino acid sequence (Bodani, R.U., et al. (2015). ACS Chem. Neurosci. 6(12):1981-1989).
ConcentrationPlease refer to lot specific datasheet.
HostRabbit
SpecificityThis polyclonal antiserum (VIA) recognizes a distinct epitope specific to Aβ-42 oligomers. VIA does not recognize classic amyloid plaques composed of fibrillar Aβ or Aβ-40 (Bodani, R.U., et al. (2015). ACS Chem. Neurosci. 6(12):1981-1989).
Species Reactivity
  • Human
Species Reactivity NoteHuman.
Antibody TypePolyclonal Antibody
Gene Symbol
  • APP
  • A4
  • AD1
Purification MethodUnpurified.
UniProt Number
Molecular WeightVariable depending on the sizes of the Aβ-42 oligmers.
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality AssuranceEvaluated by Dot Bot analysis of Aβ proteins.

Dot Blot Analysis: A 1:150 dilution of this antiserum detected recombinant Aβ-42, but not Aβ-40, oligomer.
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at -20°C from date of receipt.
Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
Packaging Information
Material Size100 µL
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
ABN1650 04054839092022